Body Systems

Neurologic Diseases6 Results found

Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)…

The purpose of this study is to assess the safety, tolerability, biomarker and cognitive efficacy of gantenerumab and solanezumab in subjects who are known to have an Alzheimer's disease-causing mutation by determining if treatment with the study drug improves cognitive outcomes and disease-relat

Principal Investigator 
Ging-Yuek Robin Hsiung
Body Locations and Systems 
Alzheimer's Disease, Neurologic Diseases, Dementia
Area 
Vancouver
Age 
18-80

Cognitive Brain Training in Older Adults

The investigators will conduct a 8-week proof-of-concept randomized controlled trial to provide preliminary evidence of efficacy of Fit Brains (Rosetta Stone Canada) training -- a mobile cognitive training program -- on cognitive and brain plasticity in older adults.

Principal Investigator 
Teresa Y.L. Liu-Ambrose
Body Locations and Systems 
Neurologic Diseases
Area 
Vancouver
Age 
65-85